PDX INSIGHTS
PIONEERING CANCER RESEARCH
Model Details

Patient Information for Model: BCM-PDAC-25

Model Contact
Model: BCM-PDAC-25
Model Contact: Qizhi Cathy Yao
Institution: BCM Pancreas PDX Program
Email: qizhiyao@bcm.edu

Patient Information
Clinical Timeline


Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection

Model Information for Model: BCM-PDAC-25

Model Details - Initial Implantation of Patient Tissue
Mutations (Cancer Gene Census List)

GeneChrStartEndRefAltcDNA ChangeCodon ChangeProtein ChangeTVAF Gene Mutation Freq. Site Mutation Freq.Most Severe EffectAll EffectsMutation ImpactTranscript IDClinVar Clinical SignificanceCOSMIC IDgnomAD Non-Cancer AFdbSNP IDGene Mutation Freq.Site Mutation Freq.Transcript IDClinVar Clinical SignificanceCOSMIC IDdbSNP ID
AFF4chr5132934659132934659TGc.406A>CAcc/Cccp.T136P0.50411Missense VariantMissense VariantMODERATEENST00000265343.10
Benign

0.002498540000rs34527550
11ENST00000265343.10Benignrs34527550
AKAP9chr79202286492022864AAAACc.4004_4006dupaaa/aAACaap.K1335_L1336insQ1.01513In-frame InsertionIn-frame InsertionMODERATEENST00000356239.8

COSV62337888
rs10644111
1513ENST00000356239.8COSV62337888rs10644111
AKAP9chr79209983192099831AGc.10858A>GAtc/Gtcp.I3620V0.562151Missense VariantMissense VariantMODERATEENST00000356239.8
Benign/Likely_benign

0.000722067000rs142729919
151ENST00000356239.8Benign/Likely_benignrs142729919
AKAP9chr79208338492083384AGc.8375A>GaAt/aGtp.N2792S0.512151Missense VariantMissense VariantMODERATEENST00000356239.8
Benign/Likely_benign
COSV62339152
0.357813000000rs6960867
151ENST00000356239.8Benign/Likely_benignCOSV62339152rs6960867
AKAP9chr79206538792065387AGc.6134A>GaAt/aGtp.N2045S0.57151Missense VariantMissense VariantMODERATEENST00000356239.8
Benign

0.000698774000rs139963188
151ENST00000356239.8Benignrs139963188
ASXL1chr203243510732435107GTc.2395G>TGat/Tatp.D799Y0.67111Missense VariantMissense VariantMODERATEENST00000375687.10
Benign
COSV60123367
0.001302110000rs143594454
11ENST00000375687.10BenignCOSV60123367rs143594454
ATMchr11108244000108244000GCc.544G>CGtt/Cttp.V182L0.418121Missense VariantMissense VariantMODERATEENST00000278616.8
Benign/Likely_benign
COSV104592414
0.002512430000rs3218707
121ENST00000278616.8Benign/Likely_benignCOSV104592414rs3218707
BCLAF1chr6136278195136278195GCc.686C>GcCt/cGtp.P229R0.66211Missense VariantMissense VariantMODERATEENST00000531224.6


0.000004223760rs753799977
11ENST00000531224.6rs753799977
BLMchr159074968790749687AGc.419A>GgAa/gGap.E140G0.43611Missense VariantMissense VariantMODERATEENST00000355112.8
Benign
COSV104665711
0.002276390000rs35886055
11ENST00000355112.8BenignCOSV104665711rs35886055
BMP5chr65587450455874504TCc.362A>GaAt/aGtp.N121S0.97711Missense VariantMissense VariantMODERATEENST00000370830.4
Benign

0.002300290000rs35124644
11ENST00000370830.4Benignrs35124644
BRCA2chr133235525032355250TCc.7397T>CgTa/gCap.V2466A0.99952Missense VariantMissense VariantMODERATEENST00000380152.7
Benign
COSV66451785
0.994912000000rs169547
52ENST00000380152.7BenignCOSV66451785rs169547
BRCA2chr133234005932340059GAc.5704G>AGat/Aatp.D1902N0.49351Missense VariantMissense VariantMODERATEENST00000380152.7
Benign
COSV104430701
0.001345760000rs4987048
51ENST00000380152.7BenignCOSV104430701rs4987048
BRD4chr191524303815243038GTc.3031C>ACcc/Accp.P1011T0.54411Missense VariantMissense VariantMODERATEENST00000263377.6



11ENST00000263377.6
CBLCchr194479358944793589AACc.1255dupgac/gaCcp.Q419Pfs*810.43333Frameshift MutationFrameshift MutationHIGHENST00000647358.2

COSV54322503

33ENST00000647358.2COSV54322503
CDH11chr166497202364972023CTc.1432G>AGtc/Atcp.V478I0.42521Missense VariantMissense VariantMODERATEENST00000268603.9
Likely_benign

0.000726566000rs80138971
21ENST00000268603.9Likely_benignrs80138971
CNV


Histology Information for Model: BCM-PDAC-25
There are no histology images for this model.













Metastasis Information for Model: BCM-PDAC-25
 
Patient
PDX
Liver
Local recurrence
Lung
Rectum
lymph node

Patient Treatment Information for Model: BCM-PDAC-25

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical ResponsePathologic ResponseReason Stopped
10folfirinoxNeoadjuvant66.1866.4391 daysStable Disease (SD)Partial Response (pPR); score 2Completed regimen













Please wait...